Speakers
President & Chief Executive Officer, DIA, United States
Prior to joining DIA in 2023, Fathallah was the Operating Officer and EVP at Ortho Clinical Diagnostics, accountable for Operations, Post Market Product Science and Engineering, Regulatory, Quality, Medical, Clinical, Scientific Affairs, and Process Excellence. Before joining Ortho...
Read More →
Founder, DEKA Research & Development Corp., United States
Serial inventor and the founder of the ARMI-Advance Regeneratve Manufacturing Institute
Director, Center for Biologics Evaluation and Research, FDA, United States
Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching...
Read More →
Co-founder, Emily Whitehead Foundation, United States
Emily Whitehead was diagnosed with acute lymphoblastic leukemia (ALL) in May 2010 when she was five years old. Typically, children diagnosed with this type of leukemia have an 85% to 90% chance of being cured; however, she relapsed twice. The leukemia became resistant to treatment...
Read More →
Co-founder and President, Emily Whitehead Foundation, United States
Emily’s parents, Tom and Kari, were not willing to give up. They heard about an experimental treatment, called CAR T-cell therapy, that was available as a Phase I clinical trial at Children’s Hospital of Philadelphia (CHOP). In April 2012, they enrolled Emily in the clinical trial...
Read More →
Chief Patient Officer, Parexel , United States
Stacy Hurt, MHA, MBA is an award-winning 25 year pharma executive who bridges the industry/consumer gap as a stage IV cancer survivor and 24/7 caregiver to her son with a rare disease. Her unique professional and personal experience position her as an esteemed patient advocate as...
Read More →
Chair, ICMRA; Executive Director, European Medicines Agency, Netherlands
Ms Cooke is Executive Director of the EMA and Chair of ICMRA. Starting her mandate as ED in June 2020 amid a public health crisis of unprecedented scale she announced “My number one priority will be to drive forward EMA’s response to the pandemic and the work already ongoing to...
Read More →
Chief Executive Officer, Neogene Therapeutics, AstraZeneca Group, Netherlands
Co-founder and CEO of Neogene Therapeutics, AstraZeneca Group will speak about his experience in developing cell therapies for cancer patients and the importance of collaboration to transform innovative science into new medicines for patients.
Deputy Director, Africa Regulatory Systems, Bill & Melinda Gates Foundation, United States
Dr. David Mukanga is Deputy Director Africa Regulatory Systems at the Bill & Melinda Gates Foundation, where he leads the foundation’s Africa regulatory systems optimization portfolio, and the linkage between regulatory systems and health care services. In this role, David supports...
Read More →
Monday June 17, 2024 8:00am - 10:00am PDT
Ballroom
San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA